Project Development
Attorneys in Paley Rothman’s project development practice group have counseled the developers of several of Montgomery County’s most noteworthy projects, serving as lead counsel in projects valued at nearly $1 billion. We advise developers on matters such as site acquisition, site development, construction, financing (including structured financing, bond financing and state/locality enhanced financing), leasing, sales and dispute resolution matters.
We work closely with clients’ land use and zoning counsel to ensure that all aspects of projects are coordinated and comply with all state and local regulations. Our project development attorneys also have extensive experience in dealing with residential planned communities.
Paley Rothman’s representative development projects include The Washingtonian Center, MedImmune’s World Headquarters and Human Genome Sciences’ headquarters, laboratories and cGMP manufacturing facilities. Several of these projects have been recognized as “Transactions of the Year” by the Greater Washington Commercial Association of Realtors and the Washington Business Journal’s “Best Real Estate Deals.”
News
February 11, 2021
SECURE ACT 2.0—Important 401(k) Legislation May Be on the Horizon
Paula Calimafde provided commentary in 401(k) Advisor article and talks about what is in the legislation and how it might benefit small businesses.
Read MoreBlog
Paley Rothman Celebrates Black History Month
Paley Rothman wishes you learning and inspiration this month.
Read MoreAwards
Glenn Cooper was ranked the No. 1 attorney in Maryland Super Lawyers for the third year in a row. Nine other attorneys were named to the 2021 Maryland Super Lawyers list and three were selected 2021 "Maryland Rising Stars."
For the ninth year in a row, Paley Rothman earned national and local honors in US News-Best Lawyers 2021 “Best Law Firms” rankings.
Paley Rothman is pleased to announce that 20 lawyers have been named to the 2021 Edition of Best Lawyers in America, and one attorney was named to the Best Lawyers: Ones To Watch list.